Factors Related To Patient Adherence To Anti Tuberculosis Drug Treatment At The Mekar Jaya Health Center

##plugins.themes.academic_pro.article.main##

Yeni Indriyani
Sutriyati Sutriyati
Rima Ernia
Muslimin Muslimin

Abstract

Regular administration of Anti Tuberculosis Drug is one of key success of tuberculosis treatmen. Discontinuing treatment, has resulted a double immune and Multu Drug Resistant (MDR) in pulmonary tuberculosis bacterias. The purpose of this study was to determine the effect of Attitude, Distance and Family Support on adherence to anti Tuberculosis Treatment. Subject and Method: This study was a cross-sectional study carried out in working area Mekar Jaya Health Center. A total sample 65 patents who diagnosed TB which cunducted in April 2021. The dependent variable was adherence to Anti Tuberculosis Drug. The independent variables were Attitude,Distance and family support. Result: The findings revealed that 61.5 % of respondents did not comply with treatment, while 38.5 %. The bivariate test results attitude was possitively associated (p-value 0.009; OR; 3.946 CI (1.364-11.416), distance p-value 0.002, OR; 5.333 CI (1.801-15.797), and family support with p-value 0.003, OR 5.091 CI (1.684-15.390) To concluded, attitude, distance and family support are associated with patient’s adherence to anti tuberculosis drug treatment.

##plugins.themes.academic_pro.article.details##

How to Cite
Indriyani, Y., Sutriyati, S., Ernia, R. and Muslimin, M. (2021) “Factors Related To Patient Adherence To Anti Tuberculosis Drug Treatment At The Mekar Jaya Health Center”, Science Midwifery, 10(1, October), pp. 170-174. Available at: https://midwifery.iocspublisher.org/index.php/midwifery/article/view/179 (Accessed: 16October2021).

References

[1] D. Rosadi, “Faktor-Faktor yang Berhubungan dengan Kepatuhan Pasien Tuberkulosis Paru Terhadap Obat Anti Tuberkulosis,” J. Berk. Kesehat., vol. 6, no. 2, p. 80, 2020, doi: 10.20527/jbk.v6i2.9452.
[2] T. R. 2020 WHO, Global Tuberculousis Report. .
[3] W. R. TBC, “No Title,” no. 2019.
[4] M. Mujamil, L. O. M. Sety, A. Zainuddin, and A. Kusnan, “Analisis Faktor Yang Berhubungan Terkait Kepatuhan Minum Obat Pasien Tuberkulosis Paru BTA+ di Masa Pandemi Covid 19 di Puskesmas Wilayah Kota Kendari,” Nurs. Updat. J. Ilm. Ilmu Keperawatan P-ISSN 2085-5931 e-ISSN 2623-2871, vol. 12, no. 2, Jun. 2021, doi: 10.36089/NU.V12I2.348.
[5] R. Rojali and N. Noviatuzzahrah, “Faktor Risiko Kepatuhan Pengobatan pada Penderita Tb Paru BTA Positif,” J. Kesehat., vol. 9, no. 1, pp. 70–79, May 2018, doi: 10.26630/JK.V9I1.754.
[6] T. Mathes, T. Jaschinski, and D. Pieper, “Adherence influencing factors - a systematic review of systematic reviews,” Arch. Public Heal., vol. 72, no. 1, Oct. 2014, doi: 10.1186/2049-3258-72-37/METRICS.
[7] Kemenkes RI, “Tuberkulosis ( TB ),” Tuberkulosis, vol. 1, no. april, p. 2018, 2018, [Online]. Available: www.kemenkes.go.id.
[8] I. S. M. Wulandari, J. Rantung, and E. Malianti, “Faktor Yang Berhubungan Dengan Kepatuhan Minum Obat Pasien TB Di Wilayah Kerja Puskesmas Parongpong,” J. Keperawatan …, vol. 5, no. 1, pp. 128–134, 2020, [Online]. Available: http://journal.um-surabaya.ac.id/index.php/JKM/article/view/4536.
[9] L. Puspitasari, B. Murti, and A. Demartoto, “Social Support on the Adherence to Treatment of Tuberculosis in Cilacap, Indonesia,” Multilevel Anal. Bio-psychosocial Environ. Factors Affect. Risk Pneumonia Infants, vol. 01, no. 01, pp. 58–65, 2016, doi: 10.26911/jepublichealth.2016.01.01.07.
[10] A. Smaje, M. Weston-Clark, R. Raj, M. Orlu, D. Davis, and M. Rawle, “Factors associated with medication adherence in older patients: A systematic review,” Aging Med., vol. 1, no. 3, pp. 254–266, Dec. 2018, doi: 10.1002/AGM2.12045.
[11] Z. S. Nezenega, L. Perimal‐lewis, and A. J. Maeder, “Factors influencing patient adherence to tuberculosis treatment in ethiopia: A literature review,” Int. J. Environ. Res. Public Health, vol. 17, no. 15, pp. 1–12, 2020, doi: 10.3390/ijerph17155626.
[12] K. O. Robsky et al., “Is distance associated with tuberculosis treatment outcomes? A retrospective cohort study in Kampala, Uganda,” BMC Infect. Dis., vol. 20, no. 1, pp. 1–9, 2020, doi: 10.1186/s12879-020-05099-z.